Filed
by the Registrant
x
|
Filed
by a Party other than the Registrant
o
|
|
o
|
Preliminary
Proxy Statement
|
|
o
|
Confidential,
for Use of the Commission Only (as permitted by
Rule 14a-6(e)(2))
|
|
x
|
Definitive
Proxy Statement
|
|
o
|
Definitive
Additional Materials
|
|
o
|
Soliciting
Material Pursuant under
Rule 14a-12
|
|
x
|
No
fee required.
|
|
o
|
Fee
computed on table below per Exchange Act Rules 14a-6(i)(1) and
0-11.
|
|
1)
|
Title
of each class of securities to which transaction
applies:
|
|
2)
|
Aggregate
number of securities to which transaction
applies:
|
|
3)
|
Per
unit price or other underlying value of transaction computed pursuant
to
Exchange Act Rule 0-11 (Set forth the amount on which the filing fee
is calculated and state how it was
determined):
|
|
4)
|
Proposed
maximum aggregate value of
transaction:
|
|
5)
|
Total
fee paid:
|
o
|
Fee
paid previously with preliminary
materials.
|
|
o
|
Check
box if any part of the fee is offset as provided by Exchange Act
Rule 0-11(a)(2) and identify the filing for which the offsetting fee
was paid previously. Identify the previous filing by registration
statement number, or the Form or Schedule and the date of its
filing.
|
|
1)
|
Amount
Previously Paid:
|
|
2)
|
Form,
Schedule or Registration Statement
No.:
|
|
3)
|
Filing
Party:
|
|
4)
|
Date
Filed:
|
VOTING PROCEDURES AND REVOCABILITY OF PROXIES | |
1 | |
COMPENSATION OF DIRECTORS | 2 |
3 | |
3 | |
4 | |
4 | |
4 | |
4 | |
5 | |
5 | |
6 | |
8 | |
9 | |
9 | |
10 | |
11 | |
11 | |
12 | |
12 | |
12 | |
13 | |
13 | |
14 | |
16 | |
16 | |
18 | |
18 | |
18 | |
AUDIT COMMITTEE CHARTER | A-1 |
|
Cordially,
|
|
|
|
Edward
J. Marino
|
|
President
and
|
|
Chief
Executive Officer
|
|
|
|
|
|
Jeffrey
A. Cook
|
|
Senior
Vice President and
|
|
Chief
Financial Officer
|
|
1.
|
To
elect eight (8) Directors to serve until the next annual meeting of
stockholders;
|
|
2.
|
To
ratify the selection of KPMG LLP as the Company's independent registered
public accounting firm for the fiscal year ending December 29,
2007; and
|
|
3.
|
To
transact such other business as may properly come before the Annual
Meeting of Stockholders and any adjournment or postponement
thereof.
|
|
By
order of the Board of Directors,
|
|
|
|
Edward
J. Marino
|
|
President
and Chief Executive Officer
|
|
|
|
Jeffrey
A. Cook
|
|
Senior
Vice President and
|
|
Chief
Financial Officer
|
PLEASE
FILL IN, DATE, SIGN AND RETURN THE ENCLOSED PROXY CARD IN THE ENVELOPE
PROVIDED AS PROMPTLY AS POSSIBLE. YOU MAY ALSO COMPLETE A PROXY BY
TELEPHONE OR VIA THE INTERNET IN ACCORDANCE WITH THE INSTRUCTIONS
LISTED
ON THE PROXY CARD. YOU MAY REVOKE YOUR PROXY AT ANY TIME PRIOR TO
EXERCISE
AS SET FORTH HEREIN, AND IF YOU ARE PRESENT AT THE MEETING YOU MAY,
IF YOU
WISH, REVOKE YOUR PROXY AT THAT TIME AND EXERCISE THE RIGHT TO VOTE
YOUR
SHARES PERSONALLY.
|
|
What
is the purpose of the Annual Meeting?
|
|
A:
|
|
At
the Annual Meeting, the Company's stockholders will be asked to vote
on
the matters listed in the accompanying notice of Annual Meeting,
namely:
|
|
|
1. the
election of eight directors;
2. to
ratify the selection of KPMG LLP as the Company's independent
registered public accounting firm
for the fiscal year ending December 29, 2007; and
3. to
transact such other business as may properly come before the Annual
Meeting of Stockholders and any adjournment or postponement
thereof.
|
|
|
Representatives
of KPMG LLP, the Company's independent
registered public accounting firm,
will also be present at the Annual Meeting, with the opportunity
to make a
statement if they desire to do so and to respond to appropriate questions
raised at the meeting.
|
Q:
|
|
|
A:
|
|
Stockholders
as of the close of business on the record date, April 17,
2007,
are entitled to vote their shares of the Company's common stock.
Each
outstanding share of common stock is entitled to one vote. At the
close of
business on the record date, there were 35,696,768 shares of the
Company's
common stock outstanding. The Company has no other voting securities
issued and outstanding. Proxies
in the accompanying form, properly executed and returned to the management
of the Company by mail, telephone or the Internet, and not revoked,
will
be voted at the Annual Meeting. Any proxy given pursuant to such
solicitation may be revoked by the stockholder at any time prior
to the
voting of the proxy by a subsequently dated proxy, by written notice
of
revocation of the proxy delivered to the Secretary of the Company,
or by
personally withdrawing the proxy at the Annual Meeting and voting
in
person.
|
Q:
|
|
How
many shares must be present to hold the
meeting?
|
A:
|
|
A
quorum must be present at the meeting for business to be conducted.
The
presence, in person or by proxy, of at least a majority of the outstanding
shares of Common Stock as of the Record Date, is necessary to establish
a
quorum for the transaction of business at the Annual Meeting.
|
Q:
|
|
What
if a quorum is not present at the meeting?
|
A:
|
|
If
a quorum is not present at the time of the meeting, the stockholders
who
are represented may adjourn the meeting until such time as a quorum
is
present. The time and place of the adjourned meeting will be announced
at
the time the adjournment is taken, and no other notice will be
given.
|
Q:
|
|
|
A:
|
|
You
may vote in any of three ways:
|
|
|
* You
may vote by mail if
you complete, sign and date the accompanying proxy card and return
it in
the prepaid envelope. Your shares will be voted confidentially and
in
accordance with your instructions;
|
|
|
* You
may vote by telephone or via the Internet in
accordance with the instructions found on your proxy card;
and
|
|
|
* You
may vote in person if
you are a registered stockholder and attend the meeting and deliver
your
completed proxy card in person. At the meeting, the Company will
also
distribute written ballots to registered stockholders who wish to
vote in
person at the meeting. Beneficial owners of shares held in "street
name"
who wish to vote at the meeting will need to obtain a proxy form
from the
institution that holds their shares.
|
Q:
|
|
How
many votes does it take to approve the items to be voted
upon?
|
A:
|
|
Directors
are elected by a plurality of votes. This means that, assuming a
quorum is
present at the meeting, director nominees will be elected if the
nominees
receive the greatest number of affirmative votes cast for the election
of
directors. All
other matters at the meeting will be decided by the affirmative vote
of
the majority cast by the shareholders present in person or represented
by
proxy and entitled to vote at the Annual Meeting.
|
Q:
|
|
Can
I revoke my proxy before it is exercised?
|
A:
|
|
Yes,
you may revoke your proxy and change your vote at any time before
the
polls close at the meeting by using any of the following
methods:
|
|
|
* by
signing another proxy with a later date;
|
|
|
* by
voting by telephone or via the Internet after the date and time of
your
last telephone or Internet vote; or
|
|
|
* if
you are a registered stockholder, by giving written notice of such
revocation to the Secretary of the Company prior to or at the meeting
or
by voting in person at the meeting.
|
Attendance
at the meeting will not automatically revoke a previously granted
proxy.
|
||
Q:
|
|
Who
will count the votes?
|
A:
|
|
The
Company will designate the Inspector(s) of Elections at the Annual
Meeting.
|
Q:
|
How
will different types of votes be counted?
|
|
A.
|
Votes
will be counted and certified by the Inspector(s) of Election. In
accordance with Delaware General Corporation Law, abstentions and
“broker
non-votes” (i.e. proxies from brokers or nominees indicating that such
persons have not received instructions from the beneficial owner
or other
persons entitled to vote shares as to a matter with respect to which
the
brokers or nominees do not have discretionary power to vote) will
be
treated as present for purposes of determining the presence of a
quorum.
Because
broker non-votes and abstentions are not considered to be votes cast,
they
will have no effect
on
the votes for the matters presented at the Annual Meeting. The proxies
received by the management of the Company will be voted in accordance
with
the instructions contained therein. Unless otherwise stated, all
shares
represented by such proxy will be voted as instructed. Proxies which
are
executed but which do not contain specific instructions will be voted
FOR
the matter in question.
|
|
Q:
|
Who
is Soliciting my proxy?
|
|
A.
|
This
solicitation is being offered by the Company, who will bear all costs
of
soliciting proxies. The Company may request its officers and regular
employees to solicit stockholders in person, by mail, e-mail, telephone,
telegraph and through the use of other forms of electronic communication.
In addition, the Company may request banks, brokers and other custodians,
nominees and fiduciaries to solicit their customers who have Common
Stock
registered in the names of a nominee and, if so, will reimburse such
banks, brokers and other custodians, nominees and fiduciaries for
their
reasonable out-of-pocket costs. Solicitation by the Company's officers
and
regular employees may also be made of some stockholders in person
or by
mail, e-mail, telephone, telegraph or through the use of other forms
of
electronic communication following the original solicitation. The
Company
may retain a proxy solicitation firm to assist in the solicitation
of
proxies. The Company will bear all reasonable solicitation fees and
expenses if such proxy solicitation firm is
retained.
|
Q:
|
|
When
are the year 2008 stockholder proposals due?
|
A:
|
|
If
a stockholder would like a proposal to be included in the Company's
Proxy
Statement for the 2008 Annual Meeting of Stockholders, (i) submit
the proposal
in
writing and addressed to the Company's Secretary no
later than December 31, 2007, and (ii) must satisfy the conditions
established by the Securities and Exchange Commission and the Company's
Certificate of Incorporation and Bylaws for stockholder proposals
in order
for the proposition to be considered for inclusion in the Company's
proxy
statement and form of proxy relating to such annual meeting. Any
such
proposals, as well as any questions related thereto, should be directed
to
the Secretary of the Company.
After
the December 31, 2007 deadline, a stockholder may submit a nomination
for
director or present a proposal suitable for stockholder action at
the
Company's 2008 Annual Meeting if it is submitted to the Company's
Secretary at the address set forth below by April 21, 2008. If a
proposal or nomination is timely submitted by such date, the stockholder
may present the proposal or make the nomination at the 2008 Annual
Meeting
but the Company is not obligated to present the matter or nominee
in its
proxy statement.
Any
such stockholder proposal or director nomination should be submitted
in
accordance with the Company's Certificate of Incorporation to Presstek,
Inc., 55 Executive Drive, Hudson, New Hampshire, 03051, Attention:
Secretary of the Corporation.
|
Q:
|
|
What
other information about the Company is
available?
|
A:
|
|
Interested
parties may submit a request to the Secretary of the Company at the
address above for a copy of the Company's Annual Report on Form 10-K
be sent to them by mail and copies of quarterly financial news releases
be
sent to them by fax or through the mail. This and other important
information about the Company is also available on our web site at
http://www.presstek.com.
|
Name
of Nominee
|
|
Age
|
|
Position
|
|
|
|
|
|
|
|
Edward
J. Marino
|
|
56
|
|
President
and Chief Executive Officer, Director
|
|
John
W. Dreyer
|
|
69
|
|
Chairman
of the Board, Director
|
|
Daniel
S. Ebenstein
|
|
64
|
|
Director
|
|
Dr.
Lawrence Howard
|
|
54
|
|
Director
|
|
Michael
D. Moffitt
|
|
67
|
|
Director
|
|
Brian
F. Mullaney
|
|
47
|
|
Director
|
|
Steven
N. Rappaport
|
|
58
|
|
Director
|
|
Donald
C. Waite, III
|
|
65
|
|
Director
|
|
1.
|
A
$22,500 annual retainer paid on the first day of July, or a pro-rata
portion thereof for Directors appointed after July 1 of a given
year;
|
2.
|
Compensation
for attendance at meetings in the amount of: (i) $1,500 for each
in-person
meeting of the Board; (ii) $500 for each telephonic meeting of the
Board;
(iii) $1,000 for each meeting of the Compensation and Stock Plan
Committee
and Nominating and Corporate Governance Committee; (iv) $1,500 for
each
meeting of the Audit Committee; and (v) $500 for each meeting of
other
committees of the Board. The Chairman of the Audit Committee also
received
an annual retainer of $7,500, paid on the first day of July each
year
during his term. Compensation for meeting attendance was paid to
non-employee directors on a quarterly
basis;
|
3.
|
Upon
joining the Board, each new non-employee director was granted an
option to
purchase 25,000 shares of the Company's Common Stock at an exercise price
per share equal to the closing price of the Common Stock on the date
the
option was granted. These options were to be fully exercisable on
the
first anniversary of the date of grant;
and
|
4.
|
On
the Company’s first business day of July, each non-employee director was
granted an option to purchase 15,000 shares of Common Stock at an
exercise
price per share equal to the closing price of the Common Stock on
that
date. These options were to be fully exercisable on the first anniversary
of the date of grant.
|
Director
|
|
|
Fees
Earned
or
Paid
in Cash
($)(a)
|
|
Options
Awards ($) (b)
|
|
Total
($)
|
|||||||
John
W. Dreyer……………………………………………
|
313,846
|
35,214
|
349,060
|
|||||||||||
Daniel
S. Ebenstein……………………………………….
|
|
|
42,000
|
|
|
35,214
|
77,214
|
|||||||
Dr.
Lawrence Howard……………………………………..
|
|
|
58,000
|
|
35,214
|
93,214
|
||||||||
Michael
D. Moffitt…………………………………………
|
|
|
42,000
|
|
|
35,214
|
77,214
|
|||||||
Brian
F. Mullaney………………………………………….
|
|
|
35,500
|
|
|
35,214
|
70,714
|
|||||||
Steven
N. Rappaport……………………………………….
|
|
|
65,500
|
(c)
|
|
35,214
|
100,714
|
|||||||
Donald
C. Waite, III………………………………………..
|
|
|
64,500
|
|
|
35,214
|
99,714
|
|||||||
(a)
|
This
column reports the amount of cash compensation earned in 2006 for
Board
and Committee service.
|
|
(b)
|
The
amount included in this column represents the amount recognized for
financial statement reporting purposes for the fiscal year ended
December
30, 2006 in accordance with Statement of Financial Accounting Standards
No. 123R, Share
Based Payment (“SFAS
No. 123R”) and thus includes amounts from awards granted in 2006.
This
estimated hypothetical value is based on a Black-Scholes option pricing
model. The Company used the following assumptions in estimating this
value: expected option life, 4.53 years; risk-free rate of return,
5.19%;
expected volatility, 53.25; and expected dividends yield, 0.0%.
As
of December 30, 2006, the following director(s) had the following
aggregate number(s) of stock options outstanding: Mr. Dreyer, 147,592,
Mr.
Ebenstein, 67,500, Dr. Howard, 65,000, Mr. Moffitt, 62,400, Mr. Mullaney,
40,000, Mr. Rappaport, 62,500, and Mr. Waite, 65,000. These
options, issued pursuant to the Company’s 2003 Stock Option and Incentive
Plan, had an estimated fair market value on the date of grant of
$4.70
based on a Black-Scholes option pricing model.
|
|
(c)
|
In
addition to this figure, Mr. Rappaport was paid a pro-rata portion
of a
prior year’s annual Board retainer fee in the amount of
$7,500.
|
Name
|
|
Age
|
|
Position
|
Edward
J. Marino*……………………………..
|
|
56
|
|
President,
Chief Executive Officer, Director
|
Jeffrey
A. Cook*………………….…………….
|
|
52
|
|
Senior
Vice President, Chief Financial Officer, and Treasurer
|
Quentin
C. Baum**……………….……………
|
|
52
|
|
Managing
Director, Presstek Europe Limited+
|
Peter
A. Bouchard**……….…………………..
|
|
43
|
|
Vice
President International Business
|
Ronald
T. Cardone***………………………….
|
|
51
|
|
Chief
Information Officer
|
Todd
H. Chambers***………………………….
|
45
|
Vice
President, Chief Marketing Officer
|
||
Gerald
N. Herman**……………………………
|
49
|
Vice
President, Corporate Controller and Chief Accounting
Officer
|
||
Geoffrey
Loftus***…………………………….
|
41
|
Vice
President, North American Service
|
||
Mark
McElhinney***…………………………..
|
|
40
|
|
President,
Lasertel, Inc.+
|
A.
Emile Tabassi***……………………………
|
|
56
|
|
Vice
President, North American Sales
|
|
*
|
Current
executive officers of the Company.
|
|||
|
**
|
Current
officers of the Company or its major subsidiaries that the Company
does
not consider among its executive officers, but which could be deemed
to
qualify as such under SEC rules. Accordingly such officers are designated
as executive officers only for the purposes of the Company's SEC
filing.
|
|||
|
***
|
Key
employees that have not been designated as executive officers of
the
Company by the Board.
|
|||
|
+
|
A
subsidiary of the Company.
|
|
·
|
motivate
executive officers to achieve our strategic objectives;
|
||||
|
·
|
align
the interests of executive officers with the interests of
shareholders;
|
||||
|
·
|
provide
competitive total compensation;
|
||||
|
·
|
attract
and retain highly qualified key executive officers; and
|
||||
|
·
|
reward
individual and corporate
performance.
|
|
·
|
base
salary;
|
||
|
·
|
bonus
compensation;
|
||
|
·
|
equity
compensation; and
|
||
·
|
fringe
benefits.
|
Name
|
Executive
Contribution in 2006
($)
|
Presstek
Contribution in 2006
($)
|
Aggregate
Earnings in 2006 ($)
|
Aggregate
Withdrawal of Distributions
($)
|
Aggregate
Balance at end of FY 2006
($)
|
||||
Edward
J. Marino
President
and Chief Executive Officer
|
25,000
|
75,000
|
21,563
|
--
|
226,669
|
Schawk,
Inc.
|
FSI
International
|
GSI
Lumonics
|
Reinhold
Industries
|
Mattson
Technology
|
Fargo
Electronics
|
Applied
Films Corp.
|
Delphax
Technologies
|
Metrologic
Instruments
|
Rimage
Corp.
|
Baldwin
Technology
|
Transact
Technologies
|
3D
Systems Corp.
|
Stratasys,
Inc.
|
|
|
Dr.
Lawrence Howard, Chairman
Steven
N. Rappaport
Brian
F. Mullaney
|
Name
and principal position
|
Year
|
Salary
($)
|
Bonus
($)
|
Option
Awards ($)(2)
|
Non-Equity
Incentive Plan Compensation ($)(3)
|
Nonqualified
Deferred Compensation Earnings
($)(4)
|
All
Other Compensation ($)(5)
|
Total
($)
|
Edward
J. Marino
President
and Chief Executive Officer
|
2006
|
450,008
|
--
|
--
|
--
|
96,563
|
20,314
|
566,885
|
Moosa
E. Moosa
Executive
Vice President and Chief Financial Officer (6)
|
2006
|
261,555
|
--
|
--
|
--
|
--
|
16,532
|
278,087
|
Quentin
C. Baum
Managing
Director Presstek Europe (7)
|
2006
|
171,087
|
--
|
--
|
50,662
|
22,780
|
16,479
|
261,008
|
Peter
A. Bouchard
Vice
President
|
2006
|
185,016
|
--
|
--
|
--
|
--
|
17,339
|
202,355
|
A.
Emile Tabassi
Vice
President North American Sales
|
2006
|
181,873
|
21,875
|
2,337
|
46,875
|
--
|
12,993
|
265,953
|
(1)
|
Except
as where otherwise specified, the compensation described in this
table
does not include medical or group life insurance or other benefits
received by the Named Executives which are available generally to
all
salaried employees of the Company and certain perquisites and other
personal benefits, or property, unless the aggregate amount of such
compensation is more than $10,000.
|
(2)
|
The
dollar amounts in this column represent the compensation cost for
the year
ended December 30, 2006 of stock option awards granted in fiscal
2006. These amounts have been calculated in accordance with SFAS
No. 123R ignoring the estimates of forfeiture and using the Black
Scholes option-pricing model. Assumptions used in the calculation
of these
amounts are included in footnote 16 to our audited financial statements
for the fiscal year ended December 30, 2006 included in our Annual
Report on Form 10-K.
|
(3)
|
This
amount includes bonus compensation that was earned in connection
with
meeting certain Company objectives at the end of each fiscal year,
but
paid in the following year.
|
(4)
|
This
amount includes deferred compensation contributed to, and $21,563
interest
earned in, a Section 409(A) plan in fiscal year 2006 for Mr. Marino,
and a
retirement payment to Mr. Baum’s retirement plan, as required by the laws
of the United Kingdom.
|
(5)
|
This
amount includes: automobile allowances, a 401(k) retirement plan
contribution match by the Company for the Named Executives, and life
insurance policy premiums paid by the Company for the benefit of
the Named
Executives.
|
ALL
OTHER COMPENSATION
|
|||||
Name
|
Automobile
Allowance
($)
|
Other
($)
|
|||
Edward
J. Marino
|
13,000
|
*
|
|||
Moosa
E. Moosa
|
13,000
|
*
|
|||
Quentin
C. Baum
|
16,479
|
*
|
|||
Peter
A. Bouchard
|
13,000
|
*
|
|||
A.
Emile Tabassi
|
9,231
|
*
|
|||
*
|
Total
value in the aggregate of less than $10,000
|
||||
(6)
|
Mr.
Moosa departed the Company, effective February 28, 2007.
|
||||
(7)
|
Mr.
Baum was also paid a bonus of $44,847 in 2006 for his performance
in 2005.
Mr.
Baum is paid in British pounds sterling and these numbers reflect
a
conversion based on the exchange rate of 1.9618 at December 30,
2006.
|
Name
|
Termination
by the Company without Cause or for “Good Reason”(a)
($)
|
Termination
on or after a Change in Control either (i) by the Company without
Cause or
(ii) by the Named Executive with Good Reason ($)
|
|||||
Edward
J. Marino (1)
|
675,000
|
1,170,000
|
|||||
Moosa
E. Moosa (1)
|
275,000
|
690,000
|
|||||
Quentin
C. Baum (1)
|
265,164
|
N/A
|
|||||
Peter
A. Bouchard
|
185,000
|
N/A
|
|||||
A.
Emile Tabassi (2)
|
200,000
|
21,034
|
(a)
|
The
agreements with Messrs. Moosa, Baum, Bouchard and Tabassi provide
for the
payment of severance benefits in the event of termination by the
company
other than for cause equal to 18 months of base salary, in the case
of Mr.
Baum, and 12 months of base salary in the case of Messrs. Moosa,
Bouchard
and Tabassi. In Mr. Baum’s case, the 18-month period is defined as a
“notice period”, which is customary in the UK and which amounts to
$256,630, and in addition to this payment, he is also entitled to
receive
$8,534, which is the statutory amount derived by a government-mandated
formula. The agreement with Mr. Marino provides for such payments
for not
less than 18 nor more than 24 months, in the event of termination
other
than for cause, and twelve months in the event of a voluntary non-renewal
of the agreement by the Company. Messrs. Bouchard and Tabassi’s
agreements each provide for a payment of 12 month base annual
salary in the event of a termination by the employee for “Good Reason”
which is defined as any reason so deemed by the Board in the exercise
of
its good faith judgment.
|
(1)
|
The
agreements with Messrs. Marino and Moosa provide for lump sum payments
to
each employee in the event of a change in control which results in
an
involuntary termination of the employee, or, in the case of Messrs.
Marino
and Moosa, termination which gives rise to termination by the employee
for
“good reason”. The lump sum payment under this provision is equal to
three times the average annual base salary over the previous five
year
period in the case of both Messrs. Marino and Moosa. The Company
neither paid nor accrued for such a payment in
2006.
|
(2)
|
Mr.
Tabassi holds options to purchase 5,000 shares that would vest upon
the
occurrence of a change in control in accordance with the terms of
the
Company’s 2003 Stock Option and Incentive
Plan.
|
GRANTS
OF PLAN-BASED AWARDS
|
||||||||
Name
|
Grant
Date
|
Estimated
Future Payouts Under Non-Equity Incentive Plan
Awards
($)
(1)
|
All
Other Stock Awards: Number of Shares of Stocks or Units
(#)
|
All
Other Option Awards: Number of Securities Underlying
Options
(#)
|
Exercise
or Base Price of Option Awards
($/Sh)
|
Grant
Date Fair Value of Stock and Option Awards
($)
|
||
Edward
J. Marino
President
and Chief Executive Officer
|
--
|
--
|
--
|
--
|
--
|
--
|
||
Moosa
E. Moosa
Executive
Vice President and Chief Financial Officer
|
--
|
--
|
--
|
--
|
--
|
--
|
||
Quentin
C. Baum
Managing
Director Presstek Europe
|
August
1, 2006
March
1, 2007
|
25,662
25,000
|
(2)
|
--
|
--
|
--
|
--
|
|
Peter
A. Bouchard
Vice
President
|
--
|
--
|
--
|
--
|
--
|
--
|
||
A.
Emile Tabassi
Vice
President North American Sales
|
September
27, 2006
May
11, 2006
March
1, 2007
|
--
21,875
25,000
|
(2)
|
--
|
5,000
--
--
|
7.70
--
--
|
21,034
--
--
|
|
(1)
|
For
purposes of this column, the “Estimated Future Payouts” amount is
estimated as of the day the plan is established.
|
|||||||
(2)
|
This
Non-Equity Incentive Plan Awards were granted in relation to the
recipient’s performance in 2006.
|
OPTION
AWARDS
|
||||
Name
|
Number
of Securities Underlying Unexercised Options
(#)
Exercisable
|
Number
of Securities Underlying Unexercised Options
(#)
Unexercisable
|
Option
Exercise Price
($)
|
Option
Expiration Date
|
Edward
J. Marino
President
and Chief Executive Officer
|
7,500
2,500
500,000
50,000
50,000
50,000
|
--
--
--
--
--
|
5.97
8.79
5.23
8.39
8.39
9.04
|
November
7, 2011
January
2, 2007
April
3, 2012
February
2, 2015
February
3, 2015
December
30, 2015
|
Moosa
E. Moosa
Executive
Vice President and Chief Financial Officer (1)
|
90,000
25,000
60,000
25,000
25,000
30,000
|
--
--
--
--
--
--
|
6.44
5.23
7.21
8.39
8.39
9.04
|
March
11, 2012
April
3, 2012
December
31, 2013
February
2, 2015
February
2, 2015
December
30, 2015
|
Quentin
C. Baum
Managing
Director Presstek Europe
|
25,000
|
--
|
9.04
|
December
30, 2015
|
Peter
A. Bouchard
Vice
President
|
10,000
2,700
25,000
25,000
15,000
|
--
--
--
--
--
|
13.75
6.30
9.91
9.91
9.04
|
April
6, 2008
February
25, 2012
November
30, 2015
November
30, 2015
December
30, 2015
|
A.
Emile Tabassi
Vice
President North American Sales
|
35,000
--
|
--
5,000
|
9.04
7.70
|
December
30, 2015
September
27, 2016
|
(1)
|
Mr.
Moosa departed the Company on February 28, 2007. Termination of his
options will be governed by the terms of his
separation.
|
|
|
(a)
Number
of securities
to be issued upon exercise of outstanding options, warrants
and rights
|
|
(b)
Weighted-average
exercise price of outstanding options, warrants and
rights ($)
|
|
(c)
Number
of securities
remaining available for future issuance under equity compensation
plans
(excluding
securities)
reflected
in
column (a))
|
|
||||||
Plan
Category
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
||||||
Equity
compensation plans approved by security holders
(1)………………………………………..
|
|
|
2,878,550
|
(3)
|
8.97
|
(3)
|
|
3,022,462
|
(4)
|
||||
Equity
compensation plans not approved by security holders
(2)………………………………
|
|
|
77,800
|
|
10.44
|
|
|
--
|
(5)
|
||||
Total……………………………………………...
|
|
|
2,956,350
|
|
9.01
|
|
|
3,022,462
|
|
||||
(1)
|
Consists
of the 1988 Plan, 1991 Plan, 1994 Plan, 1998 Plan, 2003 Plan, Director
Plan and ESPP.
|
(2)
|
Consists
of the 1997 Plan which expired on September 22, 2002. A copy of the
1997 Plan was filed as Exhibit 10.1 to the Company's quarterly report
on Form 10-Q for the quarter ended September 27, 1997 filed with
the Securities and Exchange Commission on November 7, 1997. A summary
of the 1997 Plan is provided below.
|
(3)
|
Excludes
purchase rights accruing under the
ESPP.
|
(4)
|
Includes
shares available for future issuance under the 1998 Plan and 2003
Plan.
Does not include any shares under the 1988 Plan, the 1991 Plan, and
the
1994 Plan as these plans expired on August 21, 1998, August 18,
2001, and April 8, 2004, respectively. Also includes shares available
for future issuance under the ESPP. As of December 30, 2006, an
aggregate of 769,020 shares of Common Stock were available for
issuance pursuant to the ESPP. Under the ESPP, each eligible employee
may
purchase up to 750 shares of Common Stock each quarterly purchase
period at a purchase price per share equal to 85% of the lower of
the fair
market value (as defined in the ESPP) of Common Stock on the first
or last
trading day of a purchase period. The first purchase date under the
ESPP
was December 21, 2002.
|
(5)
|
The
Company's ability to make additional option grants under the 1997
Plan
terminated on September 22,
2002.
|
Name
and Address of Beneficial Owner
|
|
Shares
Beneficially Owned(1)(2)
|
|
Percentage
of Shares Beneficially Owned(1)
|
|
||||
Peter
Kellogg and IAT Reinsurance Company Ltd……………………………………….
c/o
IAT Reinsurance Company Ltd.
48
Wall Street
New
York, NY 10005
|
7,407,178
|
(3)
|
20.8
|
%
|
|||||
Directors
|
|||||||||
Dr.
Lawrence Howard…………………………………………………………………….
|
|
|
1,334,828
|
(4)
|
|
3.7
|
%
|
||
Edward
J. Marino…………………………………………………………………………
|
|
|
685,181
|
(5)
|
|
1.9
|
%
|
||
John
W. Dreyer……………………………………………………………………………
|
|
|
165,000
|
(6)
|
|
*
|
|
||
Daniel
S. Ebenstein……………………………………………………………………….
|
|
|
53,000
|
(7)
|
|
*
|
|
||
Michael
D. Moffitt………………………………………………………………………..
|
|
|
39,840
|
(8)
|
|
*
|
|
||
Brian
F. Mullaney…………………………………………………………………………
|
|
|
25,000
|
(9)
|
|
*
|
|
||
Steven
N. Rappaport………………………………………………………………………
|
|
|
77,500
|
(10)
|
|
*
|
|
||
Donald
C. Waite, III………………………………………………………………………
|
|
|
75,000
|
(11)
|
|
*
|
|||
Executive
Officers as of December 30, 2006
|
|||||||||
Moosa
E. Moosa………………………………………………………………………….
|
|
|
309,492
|
(12)
|
|
*
|
|
||
Peter
A. Bouchard………………………………………………………………………...
|
|
|
98,900
|
(13)
|
|
*
|
|
||
Quentin
C. Baum………………………………………………………………………….
|
|
|
25,000
|
(14)
|
|
*
|
|
||
A.
Emile Tabassi………………………………………………………………………….
|
35,000
|
(15)
|
*
|
||||||
All
current executive officers and directors as a group (12
persons)…………………….
|
|
|
2,655,915
|
(16)
|
|
7.4
|
%
|
||
(1)
|
Applicable
percentage of ownership as of the Record Date is based upon 35,696,768
shares of Common Stock outstanding as of the Record Date. Beneficial
ownership is determined in accordance with the rules of the Securities
and
Exchange Commission (the “Commission”), and includes voting and investment
power with respect to shares. Common Stock subject to options currently
exercisable or exercisable within 60 days of the Record Date is
referred
to as “exercisable stock options.” Exercisable stock options are deemed
outstanding for purposes of computing the percentage ownership
of the
person holding such options, but are not deemed outstanding for
computing
the percentage of any other person.
|
(2)
|
Except
as otherwise set forth herein, the Company believes that all persons
referred to in the table have sole voting and investment power
with
respect to all shares of Common Stock reflected as beneficially
owned by
them.
|
(3)
|
As
of March 20, 2007 based on a Form 4 filed by Mr. Kellogg with the
Securities and Exchange Commission on March 22, 2007 and a Schedule
13D
filed with the Securities and Exchange Commission on April 5, 2007
by Mr.
Kellogg and IAT
Reinsurance Company Ltd. (“IAT”). According to such Schedule 13D: (i) Mr.
Kellogg is the sole owner of the voting stock of IAT and is a director,
President and CEO of IAT; (ii) as of March 16, 2006, 7,034,678
shares were
held by IAT (7,227,178
according to such Form 4, as to which shares Mr. Kellogg disclaims
beneficial ownership)
and its wholly-owned
subsidiaries, 100,000 shares were held by a foundation controlled
by Mr.
Kellogg and his wife, and 80,000 shares of Common stock were held
by
companies controlled by Mr. Kellogg, and (iii) Mr.
Kellogg had sole power to vote or direct the vote of, dispose of
or direct
the disposal of all but 100,000 of the shares reported in the Schedule
13D, as to which he had such shared voting and investment
power.
|
As
of March 20, 2007 based on a Form 4 filed with the Securities and
Exchange
Commission on March 22, 2007. Mr. Kellogg has sole power to vote
or direct
the vote of, dispose of or direct the disposal of 7,227,178 of
such shares
of which Mr. Kellogg disclaims beneficial ownership and has shared
power
to vote or direct the vote of, and to dispose of or direct the
disposal of
180,000 of such shares.
|
|
(4)
|
As
of May 15, 2006 and based on a Form 4 filed with the Securities
and
Exchange Commission on May 18, 2006. Dr. Howard is the beneficial
owner of
934,005 shares of Common Stock, of which 50,000 represent shares
subject
to stock options, which are exercisable. Dr. Howard may be deemed
to exert
sole voting and investment power over such securities. Dr. Howard
is also
the owner of 23% of the Member Interests of a limited liability
company
that is the record owner of 110,503 shares of Common Stock. Dr.
Howard's
daughter owns the other 77% of
the
|
Member
Interests of the limited liability company. Dr. Howard and Dr.
Howard's
wife are the Managing Members of the limited liability company.
Dr. Howard
may be deemed to exert shared voting and investment power over
all of the
securities held by such limited liability company. Dr. Howard
is also the
owner of 20% of
the Member Interests of another limited liability company that
is the
record owner of 182,195 shares of Common Stock. Dr. Howard's
daughter and
son own the other 80% of the Member Interests of the limited
liability
company. Dr. Howard and Dr. Howard's wife are the Managing Members
of the
limited liability company. Dr. Howard may be deemed to exert
shared voting
and investment power over all of the securities held by such
limited
liability company.
|
||||
Dr.
Howard's wife is the record owner of 35,000 shares of Common
Stock. Dr.
Howard's wife is also the record owner, as custodian for Dr.
Howard's
minor children, of 13,500 shares of Common Stock. Dr. Howard's
daughter is
the record owner of 9,625 shares. Dr. Howard may be deemed to
exert shared
voting and investment power over such securities.
|
||||
(5)
|
Includes
options to purchase 657,500 shares of Common Stock issuable pursuant
to
exercisable stock options.
|
|||
(6)
|
Includes
options to purchase 130,092 shares of Common Stock issuable pursuant
to
exercisable stock options.
|
|||
(7)
|
Includes
options to purchase 50,000 shares of Common Stock issuable pursuant
to
exercisable stock options. Also includes 3,000 shares held of
record by
Mr. Ebenstein's child with respect to which Mr. Ebenstein disclaims
any
beneficial interest.
|
|||
(8)
|
Includes
options to purchase 32,500 shares of Common Stock issuable pursuant
to
exercisable stock options.
|
|||
(9)
|
Includes
options to purchase 25,000 shares of Common Stock issuable pursuant
to
exercisable stock options.
|
|||
(10)
|
Includes
options to purchase 47,500 shares of Common Stock issuable pursuant
to
exercisable stock options.
|
|||
(11)
|
Includes
options to purchase 50,000 shares Common Stock issuable to pursuant
to
exercisable stock options.
|
|||
(12)
|
Includes
options to purchase 255,000 shares of Common Stock issuable pursuant
to
exercisable stock options.
|
|||
(13)
|
Includes
options to purchase 77,700 shares of Common Stock issuable pursuant
to
exercisable stock options.
|
|||
(14)
|
Includes
options to purchase 25,000 shares of Common Stock issuable pursuant
to
exercisable stock options.
|
|||
(15)
|
Includes
options to purchase 35,000 shares of Common Stock issuable pursuant
to
exercisable stock options.
|
|||
(16)
|
Includes
options to purchase 1,221,958 shares Common Stock issuable to
pursuant to
exercisable stock
options.
|
|
|
|
1. Obtain from the Company’s independent auditors a formal written
statement delineating all relationships between the auditors and
the
Company consistent with Independence Standards Board Standard 1 and
any
other applicable professional independence standards, actively engage
in a
dialogue with the auditors with respect to any disclosed relationships
or
services that may impact the objectivity and independence of the
auditors,
including any non-audit services provided to the Company by the auditors,
and take or recommend that the Board of Directors take appropriate
action
to oversee the independence of the auditors.
|
|
|
|
2. Evaluate the performance of the independent auditors and make
recommendations to the Board of Directors as to the selection of
the firm
of independent auditors to examine the books and accounts of the
Company
and its subsidiaries for each fiscal year (or the nomination of the
firm
of independent auditors to be proposed for stockholder approval in
any
proxy statement).
|
|
|
|
3. Meet with the independent auditors and with management to discuss
the proposed arrangement for the independent auditors for each fiscal
year, including their risk assessment process in establishing the
scope of
the examination, their proposed fees and the reports to be
rendered.
|
|
|
|
4. Review and discuss with the independent auditors and with
management the results of the year end audit of the Company, including
(a) the audit report, including particularly any qualifications
thereto, the published financial statements, the management representation
letter, any auditor response letter or memorandum prepared by and
submitted to the Company or the Committee by the independent auditors,
management’s responses thereto and any other pertinent reports;
(b) whether the external auditors have had any disagreement with
management regarding financial reporting, including whether the external
auditors have had the full cooperation of management in connection
with
the audit; and (c) other matters required to be communicated to the
Committee under generally accepted auditing standards, as amended,
by the
independent auditors.
|
|
|
|
5. Review and discuss with management and the independent auditors
the adequacy and effectiveness of the accounting and financial controls
of
the Company and elicit and report to the Board of Directors
recommendations for improvement of the Company’s internal control
procedures. Particular attention should be paid to areas where new
or more
detailed controls or procedures are desirable, or where adherence
to
existing procedures should be improved.
|
|
|
|
6. Review and discuss with management and the independent auditors
the results of reviews of the financial information to be included
in the
quarterly reports of the Company and any required communications
prior to
their filing with the Securities and Exchange
Commission.
|
|
|
|
7. Review with management and the independent auditors such
accounting policies (and changes therein) of the Company, including
any
financial reporting issues which could have a material impact on
the
Company’s financial statements, as are deemed appropriate for review by
the Committee prior to any interim or year-end filings with the Securities
and Exchange Commission or other regulators.
|
|
|
|
8. Investigate any matter brought to the attention of the Committee
and retain independent counsel, accountants or others to assist it
in
connection therewith if in the Committee’s judgment such action is
appropriate, and communicate with Company legal counsel when appropriate
to review legal and regulatory matters, if any, that may have a material
impact on the financial statements.
|
|
|
|
9. Make at least an annual self-assessment of the Committee,
including a review of the charter and updating it as
appropriate.
|
|
|
|
10. Provide a report to be included in the Company’s proxy statement
to help inform stockholders of the Committee’s oversight with respect to
financial reporting, and containing such information as may be required
by
applicable law or regulation.
|
|
|
|
11. Undertake such additional activities within the scope of its
primary function as may be required by law or
regulation.
|